Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug Administration Accelerated Approval

Ravi B. B. Parikh,Rebecca A. A. Hubbard,Erkuan Wang,Trevor J. J. Royce,Aaron B. B. Cohen,Amy S. S. Clark,Ronac Mamtani

JAMA oncology（2023）

引用 3|浏览5

暂无评分

摘要

This cross-sectional study evaluates patient exposure to oncology drugs withdrawn from the US Food and Drug Administration (FDA) Accelerated Approval program.

查看译文

关键词

us cancer drugs,drugs administration,us food

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要